Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00435201 · ClinicalTrials.gov registry record

Characterization of Clonal B Cell Populations in HCV Infection

A clinical trial of Hepatitis C, sponsored by Rockefeller University.

Completed
Registry status
14
Enrollment target
2
Study locations

NCT00435201 is a study of Hepatitis C that has completed, run by Rockefeller University. The registered enrollment target is 14 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00435201, a study of Hepatitis C, has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
14 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to investigate the mechanism of autoantibody production during chronic hepatitis C virus (HCV) infection. 10-50% of individuals with HCV have symptoms of mixed cryoglobulinemia (MC). By studying the B cells from HCV-infected individuals with and without MC, as well as from healthy controls, we hope to gain insight into the mechanisms of autoantibody production and develop new strategies for treatment of MC.

Conditions Studied

Hepatitis C

Study Locations (2)

New York

  • Rockefeller University Hospital - New York

Other

  • Oxford University - Oxford

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-01
Est. Completion 2013-06

Sponsor

Rockefeller University

117 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00435201

The ClinicalTrials.gov registry entry for NCT00435201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.

NCT00435201 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.

Frequently Asked Questions

What is clinical trial NCT00435201 about?

NCT00435201 is a clinical study titled "Characterization of Clonal B Cell Populations in HCV Infection". The purpose of this study is to investigate the mechanism of autoantibody production during chronic hepatitis C virus (HCV) infection. 10-50% of individuals with HCV have symptoms of mixed cryoglobulinemia (MC). By studying the B cells from HCV-infected individuals with and without MC, as well as fr...

What is the current status of trial NCT00435201?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2007-01. Estimated completion is 2013-06.

What conditions does trial NCT00435201 study?

This clinical trial studies the following conditions: Hepatitis C.

Who is sponsoring clinical trial NCT00435201?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00435201 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.